TuHURA BIOSCIENCES, INC./NV Proceeds from (Repayments of) Other Long-term Debt
TuHURA BIOSCIENCES, INC./NV (HURA) reported Proceeds from (Repayments of) Other Long-term Debt of $28.57 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentsOfOtherLongTermDebt · last filed 2026-03-31
- TuHURA BIOSCIENCES, INC./NV proceeds from (repayments of) other long-term debt for the quarter ending 2024-12-31 was $0.00.
- TuHURA BIOSCIENCES, INC./NV proceeds from (repayments of) other long-term debt for the quarter ending 2024-09-30 was $9.50M.
- TuHURA BIOSCIENCES, INC./NV proceeds from (repayments of) other long-term debt for the quarter ending 2024-06-30 was $14.16M.
- TuHURA BIOSCIENCES, INC./NV proceeds from (repayments of) other long-term debt for the quarter ending 2024-03-31 was $4.90M.
- TuHURA BIOSCIENCES, INC./NV proceeds from (repayments of) other long-term debt for fiscal 2024 was $28.57M, a 963.99% increase from fiscal 2023.
- TuHURA BIOSCIENCES, INC./NV proceeds from (repayments of) other long-term debt for fiscal 2023 was $2.69M.
| Period end | Proceeds from (Repayments of) Other Long-term Debt 3 month | Proceeds from (Repayments of) Other Long-term Debt 6 month | Proceeds from (Repayments of) Other Long-term Debt 9 month | Proceeds from (Repayments of) Other Long-term Debt 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $9.50M derived: sum of 2 quarters · filed 2026-03-31 | $23.66M derived: sum of 3 quarters · filed 2026-03-31 | $28.57M 10-K · filed 2026-03-31 |
| 2024-09-30 | $9.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $23.66M derived: sum of 2 quarters · filed 2025-11-14 | $28.57M 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $14.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $19.07M 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | $4.90M 10-Q · filed 2025-05-15 | |||
| 2023-12-31 | $2.69M 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |